Latest Regulatory News

Alcoa Corporation reported solid Q2 2025 operational results despite tariff headwinds and lower metal prices, completing a major joint venture sale and managing a delayed smelter restart.

Catalina Resources has strengthened its cash position through a strategic asset sale and is progressing drilling programs targeting gold and rare earth elements in Western Australia.

betr Entertainment Limited has launched an all-scrip takeover bid for PointsBet Holdings Limited, offering 3.81 betr shares for every PointsBet share, valuing PointsBet at $1.22 per share and promising significant cost synergies.

Platinum Asia Investments has released illustrative calculations for its Special Dividend and Scheme consideration tied to a proposed restructure, offering shareholders clarity ahead of a pivotal vote.

The ASX has published its latest list of entities suspended from trading for over three months, outlining key deadlines for report lodgement and trading resumption plans. Failure to meet these deadlines risks removal from the official list.

NSX Limited has updated its Scheme Implementation Deed with CNSX Markets Inc., extending the shareholder approval deadline and allowing greater flexibility in acquisition structuring.

Clean Seas Seafood’s takeover by Yumbah Aquaculture has been formally approved and registered, marking a key milestone in the seafood sector consolidation. Share trading is suspended as shareholders prepare for compensation.

United Overseas Australia Ltd has signed a binding agreement to acquire a strategic land parcel in Ho Chi Minh City, aiming to develop a substantial commercial office building. The AU$104.7 million deal marks a significant expansion into Vietnam’s growing property market.

CGN Resources has completed a significant drilling campaign at its Webb Project, uncovering new geological insights, while also expanding its tenement holdings in Western Australia's Leonora gold district and the Paterson Province's Broadhurst Project.

Imugene Limited has launched a $37.5 million equity raising through a Placement and Share Purchase Plan, offering new shares and options to fund its pivotal azer-cel clinical program. The raise includes attaching and piggyback options, subject to shareholder approval, aiming to bolster the company’s immuno-oncology pipeline.

Kinterra Capital has lodged a formal review application against the Takeovers Panel’s earlier ruling involving New World Resources, signaling potential shifts in the ongoing corporate governance saga.

Imugene Limited has launched a A$37.5 million capital raising to advance its promising off-the-shelf CAR T therapy, azer-cel, following encouraging Phase 1b data showing a 75% overall response rate in lymphoma patients.